Results for sulphonamide translation from Maltese to English

reazzjonijiet ta’ sulphonamide
sulphonamide reactions

azarga fih brinzolamide, sustanza sulphonamide.
azarga contains brinzolamide, a sulphonamide.

fosamprenavir fih nofs li tikkonsisti f’ sulphonamide.
fosamprenavir contains a sulphonamide moiety.

ambrisentan hu era mhux sulphonamide (propionic acid).
ambrisentan is a non-sulphonamide (proprionic acid) era.

jekk taf li għandek allerġija għal mediċini li fihom sulphonamide.
if you have a known allergy to medicines containing sulphonamide.

zonegran hu derivattiv ta’ benzisoxazole li fih grupp ta’ sulphonamide.
zonegran is a benzisoxazole derivative, which contains a sulphonamide group.

infezzjonijiet fiż- żwiemel ikkawżati minn mikrorganiżmi sensittivi għal trimethoprim + sulphonamide
infections in horses caused by micro-organisms sensitive to trimethoprim + sulphonamide

azopt huwa inibitur sulphonamide ta ’ carbonic anhydrase b’ assorbiment sistemiku.
azopt is a sulphonamide inhibitor of carbonic anhydrase with systemic absorption.

jekk għandek għajnejk xotti jew għandek xi problemi fil-korneja. jekk qed tieħu mediċini sulphonamide oħra
if you have dry eyes or cornea problems. if you are taking other sulphonamide medicines

azarga fih brinzolamide, inibitur sulphonamide ta’ carbonic anhydrase li huwa assorbit b’mod sistemiku.
azarga contains brinzolamide which is a sulphonamide inhibitor of carbonic anhydrase with systemic absorption.

prezista għandu jintuża b’attenzjoni f’pazjenti li huma magħrufa li għandhom allerġija għal sulphonamide.
prezista should be used with caution in patients with a known sulphonamide allergy.

sensittività eċċessiva għal sustanzi oħrajn derivati minn sulphonamides (għax hydrochlorothiazide hu prodott mediċinali derivat minn sulphonamide).
hypersensitivity to other sulphonamide-derived substances (since hydrochlorothiazide is a sulphonamide-derived medicinal product).

selexipag jgħaddi minn idrolisi enzimatika ta’ acyl sulphonamide permezz ta’ ces1 biex jagħti l-metabolit attiv.
selexipag undergoes enzymatic hydrolysis of the acyl sulphonamide by ces1 to yield the active metabolite.

pazjenti mingħajr passat ta’ allerġija għal sulphonamide ukoll jistgħu jkunu f’riskju għal reazzjonijiet serji tal- ġilda.
patients without a history of sulphonamide allergy may also be at risk for serious skin reactions.

simbrinza fih brinzolamide, inibitur sulphonamide ta’ carbonic anhydrase, u għalkemm jingħata b’mod topiku, huwa assorbit sistemikament.
simbrinza contains brinzolamide, a sulphonamide inhibitor of carbonic anhydrase and, although administered topically, is absorbed systemically.

sensittività eċċessiva għas-sustanzi attivi jew għal xi sustanzi mhux attivi (ara sezzjoni 6.1), jew għal xi derivati oħrajn ta’ sulphonamide.
hypersensitivity to the active substances or to any of the excipients (see section 6.1), or to other sulphonamide-derived substances.

reazzjonijiet avversi serji bbażati fuq l-immunità li huma assoċjati ma’ prodotti mediċinali li fihom grupp sulphonamide jinkludu raxx, reazzjoni allerġika u disturbi maġġuri ematoloġiċi, li jinkludu anemija aplastika, li b’mod rari ħafna jistgħu jkunu fatali.
serious immune based adverse reactions that are associated with medicinal products containing a sulphonamide group include rash, allergic reaction and major haematological disturbances, including aplastic anaemia, which very rarely can be fatal.